Cargando…

Anticonvulsive properties of soticlestat, a novel cholesterol 24‐hydroxylase inhibitor

OBJECTIVE: The formation of 24S‐hydroxycholesterol is a brain‐specific mechanism of cholesterol catabolism catalyzed by cholesterol 24‐hydroxylase (CYP46A1, also known as CH24H). CH24H has been implicated in various biological mechanisms, whereas pharmacological lowering of 24S‐hydroxycholesterol ha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nishi, Toshiya, Metcalf, Cameron S., Fujimoto, Shinji, Hasegawa, Shigeo, Miyamoto, Maki, Sunahara, Eiji, Watanabe, Sayuri, Kondo, Shinichi, White, H. Steve
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9311151/ https://www.ncbi.nlm.nih.gov/pubmed/35316533 http://dx.doi.org/10.1111/epi.17232

Ejemplares similares

Soticlestat, a novel cholesterol 24-hydroxylase inhibitor shows a therapeutic potential for neural hyperexcitation in mice
por: Nishi, Toshiya, et al.
Publicado: (2020)

Soticlestat, a novel cholesterol 24‐hydroxylase inhibitor, reduces seizures and premature death in Dravet syndrome mice
por: Hawkins, Nicole A., et al.
Publicado: (2021)

Population pharmacokinetics, enzyme occupancy, and 24S‐hydroxycholesterol modeling of soticlestat, a novel cholesterol 24‐hydroxylase inhibitor, in healthy adults
por: Yin, Wei, et al.
Publicado: (2023)

Preclinical characterization of [(18)F]T-008, a novel PET imaging radioligand for cholesterol 24-hydroxylase
por: Koike, Tatsuki, et al.
Publicado: (2021)

Clinical Characterization of [(18)F]T-008, a Cholesterol 24-Hydroxylase PET Ligand: Dosimetry, Kinetic Modeling, Variability, and Soticlestat Occupancy
por: Constantinescu, Cristian C., et al.
Publicado: (2023)

Oxysterols in the brain of the cholesterol 24-hydroxylase knockout mouse
por: Meljon, Anna, et al.
Publicado: (2014)

Pharmacokinetics, pharmacodynamics and safety assessment of multiple doses of soticlestat in healthy volunteers
por: Wang, Shining, et al.
Publicado: (2022)

Cholesterol 24-hydroxylase at the choroid plexus contributes to brain immune homeostasis
por: Tsitsou-Kampeli, Afroditi, et al.
Publicado: (2023)

Safety, tolerability, pharmacokinetics, pharmacodynamics, bioavailability and food effect of single doses of soticlestat in healthy subjects
por: Wang, Shining, et al.
Publicado: (2021)

Up-regulation of cholesterol 24-hydroxylase following hypoxia-ischemia in neonatal mouse brain
por: Lu, Fuxin, et al.
Publicado: (2018)

Role of cholesterol 24S-hydroxylase gene polymorphism (rs754203) in primary open angle glaucoma
por: Mossböck, Georg, et al.
Publicado: (2011)

Randomized controlled study to evaluate the efficacy and safety of soticlestat as adjunctive therapy in adults with complex regional pain syndrome
por: Ratcliffe, Stuart, et al.
Publicado: (2022)

24(S),25-Epoxycholesterol and cholesterol 24S-hydroxylase (CYP46A1) overexpression promote midbrain dopaminergic neurogenesis in vivo
por: Theofilopoulos, Spyridon, et al.
Publicado: (2019)

Is It Possible to Improve Memory Function by Upregulation of the Cholesterol 24S-Hydroxylase (CYP46A1) in the Brain?
por: Maioli, Silvia, et al.
Publicado: (2013)

The cholesterol 24-hydroxylase activates autophagy and decreases mutant huntingtin build-up in a neuroblastoma culture model of Huntington’s disease
por: Nóbrega, Clévio, et al.
Publicado: (2020)

New Phenylglycinamide Derivatives with Hybrid Structure as Candidates for New Broad-Spectrum Anticonvulsants
por: Jakubiec, Marcin, et al.
Publicado: (2022)

Research progress on the mechanism of cholesterol-25-hydroxylase in intestinal immunity
por: Zhong, Guoqiang, et al.
Publicado: (2023)

Pregnancy, epilepsy, and anticonvulsants
por: Steinhoff, Bernhard J
Publicado: (2008)

Substitution of anticonvulsant drugs
por: Steinhoff, Bernhard J, et al.
Publicado: (2009)

Neuropsychological Effects of Anticonvulsants
por: Morgan, Lindsey, et al.
Publicado: (2015)

Genomics and proteomics of vertebrate cholesterol ester lipase (LIPA) and cholesterol 25-hydroxylase (CH25H)
por: Holmes, Roger S., et al.
Publicado: (2011)

Cholesterol 25‐Hydroxylase inhibits SARS‐CoV‐2 and other coronaviruses by depleting membrane cholesterol
por: Wang, Shaobo, et al.
Publicado: (2020)

Hepatic Reduction in Cholesterol 25-Hydroxylase Aggravates Diet-induced Steatosis
por: Dong, Zeyu, et al.
Publicado: (2022)

Anticonvulsant drugs in bipolar disorder
por: Grunze, Heinz, et al.
Publicado: (1999)

The effectiveness of anticonvulsants in psychiatric disorders
por: Grunze, Heinz C. R.
Publicado: (2008)

Anticonvulsant drugs in migraine prophylaxis
por: Frediani, Fabio, et al.
Publicado: (2001)

PSYCHOSES ASSOCIATED WITH ANTICONVULSANT TOXICITY
por: Bhatia, M.S., et al.
Publicado: (1988)

Anticonvulsant Medications in Mitochondrial Disease
por: Mithal, Divakar S., et al.
Publicado: (2017)

Hepatic Cholesterol-25-Hydroxylase Overexpression Improves Systemic Insulin Sensitivity in Mice
por: Noebauer, Britta, et al.
Publicado: (2017)

Cholesterol 25-hydroxylase suppresses porcine deltacoronavirus infection by inhibiting viral entry
por: Ke, Wenting, et al.
Publicado: (2021)

Engineering substrate promiscuity in 2,4-dichlorophenol hydroxylase by in silico design
por: Wang, Ye, et al.
Publicado: (2018)

THU406 24-hydroxylase Deficiency, A Rare Cause Of Hypercalcemia
por: Hodge, Jordesha, et al.
Publicado: (2023)

Dual-Role of Cholesterol‐25‐Hydroxylase in Regulating Hepatitis B Virus Infection and Replication
por: Wei, Qi, et al.
Publicado: (2022)

Five-aza-2′-deoxycytidine-induced hypomethylation of cholesterol 25-hydroxylase gene is responsible for cell death of myelodysplasia/leukemia cells
por: Tsujioka, Takayuki, et al.
Publicado: (2015)

A phase 2, randomized, double‐blind, placebo‐controlled study to evaluate the efficacy and safety of soticlestat as adjunctive therapy in pediatric patients with Dravet syndrome or Lennox–Gastaut syndrome (ELEKTRA)
por: Hahn, Cecil D., et al.
Publicado: (2022)

An audit of therapeutic drug monitoring of anticonvulsants.
por: Sharpe, P. C., et al.
Publicado: (1995)

Influence of nebivolol on anticonvulsant effect of lamotrigine
por: Goel, Radha, et al.
Publicado: (2009)

Anticonvulsant Activity of Argyreia speciosa in Mice
por: Vyawahare, N. S., et al.
Publicado: (2009)

Anticonvulsant Effects of β-Hydroxybutyrate in Mice
por: Yum, Mi-Sun, et al.
Publicado: (2012)

The anticonvulsant of choice in pyrethroid induced convulsions
por: Senthilkumaran, Subramanian, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ghft5i8uqg4tkji33e7fr3ueo0